Figure 3
749 × 319px
· 152,1 KB
Source Paper
Liposomal Drug Delivery against Helicobacter pylori Using Furazolidone and N-Acetyl Cysteine in Augmented Therapy.Cite This Figure
 > Source: Muhammad Irfan Alam et al. "Liposomal Drug Delivery against Helicobacter pylori Using Furazolidone and N-Ace." *Pharmaceutics*, 2024. PMID: [39339161](https://pubmed.ncbi.nlm.nih.gov/39339161/)
<figure> <img src="https://pdfs.citedhealth.com/figures/39339161/194.png" alt="Figure 2. Transmission electron microscopic, TEM, images of mucopenetrative liposomes (A). MP3, cationic liposomes with Pluronic F-127 (B). MP1, neutral liposomes with Pluronic F-127. For formulations’ composition, refer to Table 1." /> <figcaption>Figure 3. Figure 2. Transmission electron microscopic, TEM, images of mucopenetrative liposomes (A). MP3, cationic liposomes with Pluronic F-127 (B). MP1, neutral liposomes with Pluronic F-127. For formulations’ composition, refer to Table 1.<br> Source: Muhammad Irfan Alam et al. "Liposomal Drug Delivery against Helicobacter pylori Using Furazolidone and N-Ace." <em>Pharmaceutics</em>, 2024. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/39339161/">39339161</a></figcaption> </figure>